Date: 2 March, 2017
Venue: Sapore Italiano, 1447 Burlingame Ave, Burlingame, CA 94010
Time: 11:30am – 1:30pm (including lunch)
Join our free lunch seminar to hear case studies describing the building blocks of a human ADME program and best practices for regulatory submissions.
In addition, this presentation covers possible non clinical ADME combinations and potential drug-drug interactions (DDI) arising from the clinical metabolite analysis. Several case studies highlight how the results from the human ADME study generate additional metabolism investigations in justification of metabolite safety.
Presentation: A complicated program made easy – simplifying the human ADME program
Iain Shaw, Director 14C Enabled Drug Development, Quotient Clinical
Register your interest today